Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02802319 · ClinicalTrials.gov registry record · NA

Ridge Preservation Following Tooth Extraction Using Porcine and Bovine Xenograft Materials

A NA study, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
NA
Development phase
44
Enrollment target

NCT02802319: Completed NA study, sponsored by The University of Texas Health Science Center at San Antonio.

NCT02802319 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02802319, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target

Study Summary

The study is a two-arm, parallel-design, randomized, prospective clinical trial designed to examine histologic wound healing following ridge preservation using bovine xenograft and porcine xenograft materials.This protocol involves procedures that are standard care. All materials are FDA-approved materials being used in an FDA-approved manner. The test group subjects will have extraction sockets grafted with porcine xenograft (Zcore). This test group will be compared to an active control group using bovine xenograft (Bio-Oss). The null hypothesis is that there will be no significant difference in formation of new vital bone between treatment groups (primary outcome). Each subjects will have a non-molar tooth extracted and the socket grafted with either test or control graft material. At the time of dental implant placement 18-20 weeks after tooth extraction a small core biopsy specimen will be removed from the implant site. The core biopsy will then be evaluated for the primary histologic outcome of % vital bone formation and secondary histologic outcome of % residual graft material.

Primary Outcome

histologic determination of % vital bone formation

Interventions

  • DEVICE Porcine Xenograft (Zcore)
  • DEVICE Bovine Xenograft (Bio-Oss)

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2016-07
Est. Completion 2018-09
Phase NA

What the finished NCT02802319 record still lists

NCT02802319 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Porcine Xenograft (Zcore) is the first listed.

NCT02802319 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02802319 about?

NCT02802319 is a clinical study titled "Ridge Preservation Following Tooth Extraction Using Porcine and Bovine Xenograft Materials". The study is a two-arm, parallel-design, randomized, prospective clinical trial designed to examine histologic wound healing following ridge preservation using bovine xenograft and porcine xenograft materials.This protocol involves procedures that are standard care. All materials are FDA-approved ma...

What is the current status of trial NCT02802319?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2016-07. Estimated completion is 2018-09.

What interventions are being tested in trial NCT02802319?

The interventions under investigation include: Porcine Xenograft (Zcore) (DEVICE), Bovine Xenograft (Bio-Oss) (DEVICE).

Who is sponsoring clinical trial NCT02802319?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02802319's enrollment target sits among peer trials

44 1423rd of 2000 higher than 566 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02802319, the US trial registry maintained by the National Library of Medicine. NCT02802319 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.